Founded in 1990, TecMinho is a private non-profit association, having had as sponsors the University of Minho and the Association of Municipalities of Vale do Ave. Its basic mission is to be an interface of the University of Minho, promoting its connection to society, especially in the areas of science and technology, contributing to regional development by improving the competitiveness of organizations and increase the skills of individuals. Our quest for innovation and technological development takes place through 3 main lines of action: Continuing Training, Technology Transfer and University Entrepreneurship.  TecMinho's Intervention Strategy: - Promotion of innovation and development of new technologies / products / processes and their transfer to businesses; - Promotion of Continuous Training activities (including e-learning), as well as organizational development and transnational mobility of human resources; - Support to the creation of enterprises, with emphasis on academic spin-offs; - Kick-start of projects of research / development, as well as guidance in its implementation.

A Janssen é uma companhia farmacêutica, líder mundial em Investigação, que se dedica há mais de 60 anos ao desenvolvimento de medicamentos inovadores, com o objetivo de melhorar a qualidade e aumentar a esperança de vida de milhões de doentes em todo o mundo. Em Portugal, a Janssen conta com uma equipa de cerca de 100 colaboradores que contribuem para melhorar a saúde dos doentes e criar valor económico para o País. A Janssen integra um grupo mundial de companhias farmacêuticas: Faz parte do grupo Johnson & Johnson, com sede em New Brunswick, EUA; 35.000 colaboradores nos 5 continentes; Investiu cerca de €7 mil milhões em Investigação e Desenvolvimento em 2014; 5ª Maior Farmacêutica a nível global. A Janssen na Europa, Médio Oriente & África (EMEA) tem... Atividade em mais de 100 países; Escritórios em mais de 30 países; Mais de 14.000 colaboradores; Investimento em investigação e desenvolvimento é superior a €1,5 mil milhões, anualmente. Temos 8 centros de Investigação e Desenvolvimento na zona EMEA: Beerse, na Belgica; High Wycombe, no Reino Unido; Leiden (Janssen Biologics & Crucell), na Holanda; Val-de-Reuil, em França; Schaffhausen e Bern (Crucell), na Suíça; Toledo, em Espanha. Na região EMEA, temos 10 locais de produção, que produzem medicamentos para distribuição a nível global: Beerse, Geel e Olen, na Bélgica; Cork, na Irlanda; Latina, em Itália; Leiden, na Holanda; Madrid, (Crucell) em Espanha; Schaffhausen e Bern (Crucell), na Suíça; Solna (Crucell), na Suécia.

i2Biotech es una empresa que ofrece servicios de gestión y dirección de proyectos de investigación, consultoría estratégica y de innovación constituida por un equipo multidisciplinar entre los que se encuentran doctores en tecnología de los alimentos, biología y química, con amplia experiencia y especialización en servicios de I+D+i y en la gestión de proyectos. La capacidad de investigación, apoyada en la experiencia de nuestro equipo técnico, nos permite actuar de forma creativa y prestar a nuestros clientes servicios de alto contenido tecnológico. Áreas de trabajo: - Servicios I+D+i - Vigilancia tecnológica - Gestión de proyectos - Programas europeos - Aceleración de resultados de investigación - Preparación de informes de competidores - Estudios de mercado -Internacionalización de la I+D+i -Deducciones fiscales I+D+i

GLECEX is start-up focused on research and development in biotechnology. The SME offers advanced services to companies in the agro-food, cosmetic and nutraceutical sectors based on its high technological and innovative capacity. - Chemical characterization of ingredients, extracts and final products - Development of healthier food formulations with natural ingredients (personalized nutrition) - Development of green technologies for the extraction of bioactive compounds - Studies of bioactivities and synergistic effects. in vitro assays in cell-free systems (antioxidant and anti-inflammatory activities, enzyme inhibitor screening assays related to metabolic syndrome and cosmetic efficacy, etc.). - Stability and lipid oxidation studies in model formulations

Free training co-organized by C2ICB and HCP/TRIS-HCP, with the collaboration of CUF, Infarmed and INPI.

Opportunities in Germany’s health market for Portuguese companies and R&D centres. Co-organized by Health Cluster Portugal and AICEP Portugal Global - Trade & Investment Agency.

Bioga organiza la Bio Investor Academy,https://bioga.us13.list-manage.com/track/click?u=750012ee898327de64a8a5168&id=0f05f3dc52&e=e6f3baa971 proyecto de formación y mentorizaje previo a la Lonja de Inversores. Esta acción está promovida y financiada por la Xunta de Galicia a través de la Axencia Galega de Innovación (GAIN) y el Parque Tecnolóxico de Galicia (Tecnópole) bajo el paraguas del Programa Agrobiotech Innovación.Este proyecto de formación y mentorizaje permitirá analizar, completar y mejorar su plan de negocio a los emprendedores y a las empresas más innovadoras del sector de las ciencias de la vida gallego antes de la celebración de la Lonja de Inversores. Bio Investor Academy les facilitará el acceso a la captación de financiación, fundamentalmente del sector privado, mediante la presentación de su proyecto ante un conjunto de inversores bajo el esquema networking. Consulta el programa de Bio Investor Academy.Dirigido a Investigadores y emprendedores de sectores bio.Proyectos emprendedores de universidades gallegas.Empresas que quieran consolidar en el mercado su proyecto bio.

UN-EM is a company created to advise Universities and Technological Centers to transfer research results to the market. The staff is specialized in technologies valuation, boosting entrepreneurship and the creation of Spin-Off companies. UN-EM facilitate the commercial exploitation of scientific results. The company is based on knowledge and methodologies which allows break down geographical barriers, with customers in Spain and Latin America.

  Experienced Director of Global Strategic Program and Portfolio Management with a demonstrated background in biotechnology industry with several products taken from early development to commercialization. Passionate and skilled in strategy, team management, with strong interpersonal skills fostering customer happiness. MBA graduate with major in entrepreneurship. Private Investor and Board Member at Qubiotech Health Intelligence and ChemoSapiens